 isolated hepatocytes, dichloroacetate directly activates pyruvate dehydrogenase whereas biotransformation product, oxalate, inhibits pyruvate carboxylase pyruvate kinase. Dichloroacetate, decreases blood lactate efficiently, sucessfully tested acute treatment congenital lactic acidosis, transformation oxalate potential chronic toxicity prompt replace 2-chloropropionate therapeutic agent.